Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
DeepEMhancer: a deep learning solution for cryo-EM volume post-processing
For those adjusting to new regimens or experiencing side effects, Gala offers symptom-based recommendations that help optimize their health journey
(2023) Retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in type 2 diabetes N Engl J Med 389(6):503-513
What the Brand Says About How These Medications May Work The brand's materials describe semaglutide as a medication that "may work through the GLP-1 pathway" and tirzepatide as one that "may work through both GIP and GLP-1 pathways." Per the official website, GLP-1-based treatment "may be considered as part of a broader provider-guided care plan for weight care," and the brand frames weight care generally as involving "a range of factors, including appetite signaling, metabolism, and overall health history" - not a single mechanism or a guaranteed outcome
Achieving optimal tissue repair through MARL with reward shaping and curriculum learning
US$ 20.38
US$ 20.20
US$ 25.32
US$ 25.03
US$ 26.24
US$ 26.43
US$ 28.07
%20(1).png)
